why choose us

Clinical Trials Search

Showing 14,980 of 132,656 result(s)
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC;BPS

Status: Completed

Condition: Interstitial Cystitis

Interventions: VNX001 (alkalinized lidocaine HCl and heparin sodium)

Date: 2023-02-10

PCMS Task After Moderate-to-severe Stroke

Status: Completed

Condition: Stroke

Interventions: 120 pairs of TMS and PNS volleys will be administered during electromyography-triggered functional electrical stimulation (FES)-assisted task-specific

Date: 2023-02-10

Therapy Program for Academic Skills in Children With Intellectual Disability

Status: COMPLETED

Condition: Intellectual Disability, Mild

Interventions: A combined program based on physical and occupational therapy techniques within a play context

Date: 2023-02-10

To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone

Status: NOT_YET_RECRUITING

Condition: Submucous Leiomyoma of Uterus

Interventions: Patients with fibroid remained will be enrolled and divided into three groups.
one group wii be administrated with Zoladex (3.60mg;28 days)

Date: 2023-02-10

Collection of Circulating Biomarkers in Pancreatic Cancer

Status: Completed

Condition: Pancreas Cancer

Interventions: 4 tbsp of blood in a 1-week period, occurring no more frequently than 4 times in an 8-week period

Date: 2023-02-10

Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

Status: Completed

Condition: Solid Tumor

Interventions: KRAS G12D Inhibitor

Date: 2023-02-10

Safety and Clinical Activity of KT-253 in Adult Patients With High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

Status: Completed

Condition: Myeloid Malignancies

Interventions: KT-253 will be administered intravenously per the defined protocol frequency and dose level.

Date: 2023-02-10

Expanded Access to Ziftomenib

Status:

Condition: Acute Lymphoblastic Leukemia, With Appropriate Mutations
Acute Myeloid Leukemia, With NPM1 Muta

Interventions: Drug: ziftomenib

Date: 2023-02-10

The Effect of Exercise in Water on Functional Fitness in People With Parkinson's Disease

Status: Completed

Condition: Parkinson
Parkinson Disease
Neurologic Disorder

Interventions: Interventional

Date: 2023-02-10